Neuroendocrine mechanisms in insulin resistance

Molecular and Cellular Endocrinology

Volumn 297, Issue 1-2, 2009, Pages 104-111

  Sjöstrand, Mikaela ^a,b   Eriksson, Jan W ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Adipose tissue; Insulin resistance; Neuroendocrine; Stress

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; REACTIVE OXYGEN METABOLITE;

ADRENERGIC SYSTEM; ARTICLE; CELL STRESS; DISEASE ASSOCIATION; ENDOTHELIUM; GLUCOSE TRANSPORT; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; NEUROENDOCRINOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; SYMPATHETIC TONE;

ANIMALS; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM; GLUCOSE; HUMANS; INSULIN RESISTANCE; NEUROSECRETORY SYSTEMS; STRESS, PHYSIOLOGICAL;

EID: 57649153175     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.05.010     Document Type: Article

References (92)

1. Abdallah B.M., Beck-Nielsen H., and Gaster M. Increased expression of 11B-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes. Eur. J. Clin. Invest. 35 (2005) 627-634
2. Abraham N.G., Brunner E.J., Eriksson J.W., and Robertson R.P. Metabolic syndrome: psychosocial, neuroendocrine, and classical risk factors in type 2 diabetes. Ann. NY Acad. Sci. 1113 (2007) 256-275
3. Agardh E.E., Ahlbom A., Andersson T., Efendic S., Grill V., Hallqvist J., Norman A., and Ostenson C.-G. Work stress and low sense of coherence is associated with type 2 diabetes in middle-aged swedish women. Diabetes Care 26 (2003) 719-724
4. Ahren B., and Holst J.J. The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. Diabetes 50 (2001) 1030-1038
5. Andersson B., Mårin P., Lissner L., Vermeulen A., and Björntorp P. Testosterone concentration in women and men with NIDDM. Diabetes Care 17 (1994) 405-411
6. Andersson B., Mattsson L.-A., Hahn L., Lapidus L., Holm G., Bengtsson B.-A., and Bjorntorp P. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 82 (1997) 638-643
7. Andrews R.C., Herlihy O., Livingstone D.E.W., Andrew R., and Walker B.R. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. J. Clin. Endocrinol. Metab. 87 (2002) 5587-5593
8. Arner P. Human fat cell lipolysis: biochemistry, regulation and clinical role. Adipose Tissue as an Endocrine Organ. Best Pract. Res. Clin. Endocrinol. Metab. 19 (2005) 471-482
9. Basu R., Singh R.J., Basu A., Chittilapilly E.G., Johnson C.M., Toffolo G., Cobelli C., and Rizza R.A. Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-{beta} hydroxysteroid dehydrogenase (11{beta}-HSD) type 1 pathway. Diabetes 53 (2004) 2051-2059
10. Battilana P., Seematter G., Schneiter P., Jequier E., and Tappy L. Effects of free fatty acids on insulin sensitivity and hemodynamics during mental stress. J. Clin. Endocrinol. Metab. 86 (2001) 124-128
11. Benthem L., Keizer K., Wiegman C.H., de Boer S.F., Strubbe J.H., Steffens A.B., Kuipers F., and Scheurink A.J. Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E1286-E1293
12. Bjorntorp P., and Rosmond R. Neuroendocrine abnormalities in visceral obesity. Int. J. Obes. Relat. Metab. Disord. 24 Suppl. 2 (2000) S80-S85
13. Bjorntorp P., Holm G., and Rosmond R. Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus. Diabet. Med. 16 (1999) 373-383
14. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
15. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54 (2005) 1615-1625
16. Bruce D.G., Chisholm D.J., Storlien L.H., Kraegen E.W., and Smythe G.A. The effects of sympathetic nervous system activation and psychological stress on glucose metabolism and blood pressure in subjects with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35 (1992) 835-843
17. Brunner E.J., Hemingway H., Walker B.R., Page M., Clarke P., Juneja M., Shipley M.J., Kumari M., Andrew R., Seckl J.R., Papadopoulos A., Checkley S., Rumley A., Lowe G.D., Stansfeld S.A., and Marmot M.G. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation 106 (2002) 2659-2665
18. Brydon L., Wright C.E., O'Donnell K., Zachary I., Wardle J., and Steptoe A. Stress-induced cytokine responses and central adiposity in young women. Int. J. Obes. (2007)
19. Buren J., and Eriksson J.W. Is insulin resistance caused by defects in insulin's target cells or by a stressed mind?. Diabetes Metab. Res. Rev. 21 (2005) 487-494
20. Buren J., Lindmark S., Renstrom F., and Eriksson J.W. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?. Metabolism 52 (2003) 239-245
21. Cannon W.B. Organization for physiological homeostasis. Physiol. Rev. 9 (1929) 399-431
22. Carpentier A., Zinman B., Leung N., Giacca A., Hanley A.J.G., Harris S.B., Hegele R.A., and Lewis G.F. Free fatty acid-mediated impairment of glucose-stimulated insulin secretion in nondiabetic Oji-Cree individuals from the Sandy Lake Community of Ontario, Canada: a population at very high risk for developing type 2 diabetes. Diabetes 52 (2003) 1485-1495
23. Chandrashekara S., Jayashree K., Veeranna H.B., Vadiraj H.S., Ramesh M.N., Shobha A., Sarvanan Y., and Vikram Y.K. Effects of anxiety on TNF-[alpha] levels during psychological stress. J. Psychosom. Res. 63 (2007) 65-69
24. de Jongh R.T., Serne E.H., IJzerman R.G., de Vries G., and Stehouwer C.D.A. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 109 (2004) 2529-2535
25. Delaunay F., Khan A., Cintra A., Davani B., Ling Z.C., Andersson A., Ostenson C.G., Gustafsson J., Efendic S., and Okret S. Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. J. Clin. Invest. 100 (1997) 2094-2098
26. Desbriere R., Vuaroqueaux V., Achard V., Boullu-Ciocca S., Labuhn M., Dutour A., and Grino M. 11{beta}-Hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients. Obesity 14 (2006) 794-798
27. Eller N.H., Netterstrom B., and Hansen A.M. Psychosocial factors at home and at work and levels of salivary cortisol. Biol. Psychol. 73 (2006) 280-287
28. Engeli S., Schling P., Gorzelniak K., Boschmann M., Janke J., Ailhaud G., Teboul M., Massiéra F., and Sharma A.M. The adipose-tissue rennin-angiotensin-aldosterone system: role in the metabolic syndrome? Renin-angiotensin systems: state of the art. Int. J. Biochem. Cell Biol. 35 (2003) 807-825
29. Eriksson J.W. Metabolic stress in insulin's target cells leads to ROS accumulation-a hypothetical common pathway causing insulin resistance. FEBS Lett. 581 (2007) 3734
30. Evans J.L., Goldfine I.D., Maddux B.A., and Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 23 (2002) 599-622
31. Evans J.L., Maddux B.A., and Goldfine I.D. The molecular basis for oxidative stress-induced insulin resistance. Antioxid. Redox Signal. 7 (2005) 1040-1052
32. Ferder L., Inserra F., and Martinez-Maldonado M. Inflammation and the metabolic syndrome: role of angiotensin II and oxidative stress. Curr. Hypertens. Rep. 8 (2006) 191-198
33. Franco C., Brandberg J., Lonn L., Andersson B., Bengtsson B.-A., and Johannsson G. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial. J. Clin. Endocrinol. Metab. 90 (2005) 1466-1474
34. Frontoni S., Bracaglia D., Baroni A., Pellegrini F., Perna M., Cicconetti E., Ciampittiello G., Menzinger G., and Gambardella S. Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type 2 diabetic patients. Hypertension 41 (2003) 1223-1227
35. Ghiadoni L., Donald A.E., Cropley M., Mullen M.J., Oakley G., Taylor M., O'Connor G., Betteridge J., Klein N., Steptoe A., and Deanfield J.E. Mental stress induces transient endothelial dysfunction in humans. Circulation 102 (2000) 2473-2478
36. Harman-Boehm I., Bluher M., Redel H., Sion-Vardy N., Ovadia S., Avinoach E., Shai I., Kloting N., Stumvoll M., Bashan N., and Rudich A. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the co-morbidities of obesity. J. Clin. Endocrinol. Metab. (2007)
37. Holmang A., and Bjorntorp P. The effects of testosterone on insulin sensitivity in male rats. Acta Physiol. Scand. 146 (1992) 505-510
38. Houstis N., Rosen E.D., and Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440 (2006) 944-948
39. Huggett R.J., Scott E.M., Gilbey S.G., Bannister J., Mackintosh A.F., and Mary D.A. Disparity of autonomic control in type 2 diabetes mellitus. Diabetologia 48 (2005) 172-179
40. Huggett R.J., Hogarth A.J., Mackintosh A.F., and Mary D.A. Sympathetic nerve hyperactivity in non-diabetic offspring of patients with type 2 diabetes mellitus. Diabetologia 49 (2006) 2741-2744
41. Jang C., Obeyesekere V.R., Dilley R.J., Krozowski Z., Inder W.J., and Alford F.P. Altered activity of 11{beta}-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2. Diabetes (2007)
42. Johannsson G., Marin P., Lonn L., Ottosson M., Stenlof K., Bjorntorp P., Sjostrom L., and Bengtsson B.-A. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J. Clin. Endocrinol. Metab. 82 (1997) 727-734
43. Johansson J.-O., Fowelin J., Landin K., Lager I., and Bengtsson B.-A. Growth hormone-deficient adults are insulin-resistant. Metabolism 44 (1995) 1126-1129
44. Jordan J., Tank J., Stoffels M., Franke G., Christensen N.J., Luft F.C., and Boschmann M. Interaction between {beta}-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism. J. Clin. Endocrinol. Metab. 86 (2001) 2803-2810
45. Kahn B.B., and Flier J.S. Obesity and insulin resistance. J. Clin. Invest. 106 (2000) 473-481
46. Kashyap S., Belfort R., Gastaldelli A., Pratipanawatr T., Berria R., Pratipanawatr W., Bajaj M., Mandarino L., DeFronzo R., and Cusi K. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52 (2003) 2461-2474
47. Kershaw E.E., Morton N.M., Dhillon H., Ramage L., Seckl J.R., and Flier J.S. Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes 54 (2005) 1023-1031
48. Knutson K.L., Spiegel K., Penev P., and Van Cauter E. The metabolic consequences of sleep deprivation. Sleep Med. Rev. 11 (2007) 163-178
49. Kreier F., Fliers E., Voshol P.J., Van Eden C.G., Havekes L.M., Kalsbeek A., Van Heijningen C.L., Sluiter A.A., Mettenleiter T.C., Romijn J.A., Sauerwein H.P., and Buijs R.M. Selective parasympathetic innervation of subcutaneous and intra-abdominal fat-functional implications. J. Clin. Invest. 110 (2002) 1243-1250
50. Kyrou I., Chrousos G.P., and Tsigos C. Stress, visceral obesity, and metabolic complications. Ann. NY Acad. Sci. 1083 (2006) 77-110
51. Laitinen T., Vauhkonen I., Niskanen L., Hartikainen J., Lansimies E., Uusitupa M., and Laakso M. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes 48 (1999) 1295-1299
52. Lautt W.W., Macedo M.P., Sadri P., Takayama S., Duarte Ramos F., and Legare D.J. Hepatic parasympathetic (HISS) control of insulin sensitivity determined by feeding and fasting. Am. J. Physiol. Gastrointest. Liver Physiol. 281 (2001) G29-G36
53. Li X., Lindquist S., Chen R., Myrnas T., Angsten G., Olsson T., and Hernell O. Depot-specific messenger RNA expression of 11[beta]-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults. Int. J. Obes. 31 (2006) 820
54. Lind L., Pollare T., Berne C., and Lithell H. Long-term metabolic effects of antihypertensive drugs. Am. Heart J. 128 (1994) 1177-1183
55. Lindmark S., Lonn L., Wiklund U., Tufvesson M., Olsson T., and Eriksson J.W. Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance. Obes. Res. 13 (2005) 717-728
56. Lindmark S., Buren J., and Eriksson J.W. Insulin resistance, endocrine function and adipokines in type 2 diabetes patients at different glycaemic levels: potential impact for glucotoxicity in vivo. Clin. Endocrinol. (Oxf) 65 (2006) 301-309
57. Lundgren M., Buren J., Ruge T., Myrnas T., and Eriksson J.W. Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes. J. Clin. Endocrinol. Metab. 89 (2004) 2989-2997
58. Lundgren M., Svensson M., Lindmark S., Renstrom F., Ruge T., and Eriksson J.W. Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'. Diabetologia 50 (2007) 625-633
59. Marin P., and Arver S. Androgens and abdominal obesity. Baillieres Clin. Endocrinol. Metab. 12 (1998) 441-451
60. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., and Flier J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science 294 (2001) 2166-2170
61. Mather K.J., Lteif A., Steinberg H.O., and Baron A.D. Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes. Diabetes 53 (2004) 2060-2066
62. McEwen B.S. Protective and damaging effects of stress mediators. N. Engl. J. Med. 338 (1998) 171-179
63. Moan A., Hoieggen A., Nordby G., Os I., Eide I., and Kjeldsen S.E. Mental stress increases glucose uptake during hyperinsulinemia: associations with sympathetic and cardiovascular responsiveness. Metabolism 44 (1995) 1303-1307
64. Montague C., and O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49 (2000) 883-888
65. Navegantes L.C.C., Sjostrand M., Gudbjornsdottir S., Strindberg L., Elam M., and Lonnroth P. Regulation and counterregulation of lipolysis in vivo: different roles of sympathetic activation and insulin. J. Clin. Endocrinol. Metab. 88 (2003) 5515-5520
66. Paulsen S.K., Pedersen S.B., Fisker S., and Richelsen B. 11{beta}-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity 15 (2007) 1954-1960
67. Phillips D.I., Caddy S., Ilic V., Fielding B.A., Frayn K.N., Borthwick A.C., and Taylor R. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 45 (1996) 947-950
68. Plomgaard P., Bouzakri K., Krogh-Madsen R., Mittendorfer B., Zierath J.R., and Pedersen B.K. Tumor necrosis factor-{alpha} induces skeletal muscle insulin resistance in healthy human subjects via inhibition of AKT substrate 160 phosphorylation. Diabetes 54 (2005) 2939-2945
69. Quisth V., Enoksson S., Blaak E., Hagstrom-Toft E., Arner P., and Bolinder J. Major differences in noradrenaline action on lipolysis and blood flow rates in skeletal muscle and adipose tissue in vivo. Diabetologia 48 (2005) 946-953
70. Qvisth V., Hagstrom-Toft E., Enoksson S., Moberg E., Arner P., and Bolinder J. Human skeletal muscle lipolysis is more responsive to epinephrine than to norepinephrine stimulation in vivo. J. Clin. Endocrinol. Metab. 91 (2006) 665-670
71. Ramsay L.E., Yeo W.W., and Jackson P.R. Metabolic effects of diuretics. Cardiology 84 Suppl. 2 (1994) 48-56
72. Randle P.J. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab. Rev. 14 (1998) 263-283
73. Rask E., Olsson T., Soderberg S., Andrew R., Livingstone D.E., Johnson O., and Walker B.R. Tissue-specific dysregulation of cortisol metabolism in human obesity. J. Clin. Endocrinol. Metab. 86 (2001) 1418-1421
74. Rasouli N., Molavi B., Elbein S.C., and Kern P.A. Ectopic fat accumulation and metabolic syndrome. Diabetes Obes. Metab. 9 (2007) 1-10
75. Rattigan S., Clark M., and Barrett E. Acute vasoconstriction-induced insulin resistance in rat muscle in vivo. Diabetes 48 (1999) 564-569
76. Rizza R.A., Mandarino L.J., and Gerich J.E. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J. Clin. Endocrinol. Metab. 54 (1982) 131-138
77. Robertson R.P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol. Chem. 279 (2004) 42351-42354
78. Rocca A.S., and Brubaker P.L. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 140 (1999) 1687-1694
79. Scherrer U., Randin D., Tappy L., Vollenweider P., Jequier E., and Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 89 (1994) 2634-2640
80. Seematter G., Guenat E., Schneiter P., Cayeux C., Jequier E., and Tappy L. Effects of mental stress on insulin-mediated glucose metabolism and energy expenditure in lean and obese women. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E799-E805
81. Sharma A.M., Janke J., Gorzelniak K., Engeli S., and Luft F.C. Angiotensin blockade prevents type 2 diabetes by formation of fat cells. Hypertension 40 (2002) 609-611
82. Shiloah E., Witz S., Abramovitch Y., Cohen O., Buchs A., Ramot Y., Weiss M., Unger A., and Rapoport M.J. Effect of acute psychotic stress in nondiabetic subjects on {beta}-cell function and insulin sensitivity. Diabetes Care 26 (2003) 1462-1467
83. Stein P.K., Barzilay J.I., Domitrovich P.P., Chaves P.M., Gottdiener J.S., Heckbert S.R., and Kronmal R.A. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study. Diabet. Med. 24 (2007) 855-863
84. Sung B.H., Wilson M.F., Izzo Jr. J.L., Ramirez L., and Dandona P. Moderately obese, insulin-resistant women exhibit abnormal vascular reactivity to stress. Hypertension 30 (1997) 848-853
85. Valsamakis G., Anwar A., Tomlinson J.W., Shackleton C.H.L., McTernan P.G., Chetty R., Wood P.J., Banerjee A.K., Holder G., Barnett A.H., Stewart P.M., and Kumar S. 11{beta}-Hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 89 (2004) 4755-4761
86. van den Meiracker A.H., and Boomsma F. The angiotensin II-sympathetic nervous system connection [comment]. J. Hypertens. 21 (2003) 1453-1454
87. Ward A.M.V., Syddall H.E., Wood P.J., Dennison E.M., and Phillips D.I.W. Central hypothalamic-pituitary-adrenal activity and the metabolic syndrome: studies using the corticotrophin-releasing hormone test. Metabolism 53 (2004) 720
88. Wei Y., Sowers J.R., Clark S.E., Li W., Ferrario C.M., and Stump C.S. Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-{kappa}B activation via NADPH oxidase. Am. J. Physiol. Endocrinol. Metab. 294 (2008) E345-E351
89. White M., Lepage S., Lavoie J., De Denus S., Leblanc M.H., Gossard D., Whittom L., Racine N., Ducharme A., Dabouz F., Rouleau J.L., and Touyz R. Effects of combined candesartan and ACE inhibitors on BNP, markers of inflammation and oxidative stress, and glucose regulation in patients with symptomatic heart failure. J. Card. Fail. 13 (2007) 86-94
90. Xie H., and Lautt W.W. Insulin resistance caused by hepatic cholinergic interruption and reversed by acetylcholine administration. Am. J. Physiol. Endocrinol. Metab. 271 (1996) E587-E592
91. Youd J., Rattigan S., and Clark M. Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha. Diabetes 49 (2000) 1904-1909
92. Zierath J.R., Galuska D., Nolte L.A., Thorne A., Kristensen J.S., and Wallberg-Henriksson H. Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance. Diabetologia 37 (1994) 270-277